文献速递神经肿瘤

非典型垂体腺瘤:临床病理病例系列

Atypical pituitary adenoma: a clinicopathologic case series.
PubMed 文献 · J Neurosurg · 2017-06-09

该研究回顾了2007年至2014年加州大学旧金山分校701例垂体腺瘤切除术患者,其中122例有核分裂活性者评估全部3项非典型性标志物,36例(5%)为非典型腺瘤;非典型腺瘤更常见于年轻患者、体积更大、更多为功能性且复发更早,支持其作为独立临床实体。

要点

  • 非典型垂体腺瘤占701例切除术的5%(36例)。
  • 非典型腺瘤患者平均37岁,低于非典型腺瘤的49岁(p<0.001)。
  • 功能性非典型腺瘤较功能性非典型腺瘤更早复发(中位56 vs 129个月,p<0.001)。

核心结论

  • 与非典型垂体腺瘤相比,非典型腺瘤更常见于年轻患者、体积更大、更多为激素高分泌性,并与更早复发相关,支持其作为独立临床实体。

研究设计与样本

  • 回顾性病例系列,纳入2007年至2014年加州大学旧金山分校701例垂体腺瘤切除术患者。
  • 按机构方案,对有核分裂活性的腺瘤评估全部3项非典型性标志物(核分裂指数、广泛p53染色、MIB-1指数≥3%)。
  • 统计方法包括χ2检验、Fisher精确检验、t检验、log-rank检验和逻辑回归。

主要发现

  • 701例中122例有核分裂活性并评估3项标志物,36例(5%)为非典型腺瘤。
  • 非典型腺瘤组女性21例(58%)、男性15例(42%),非非典型腺瘤组女性313例(47%)、男性352例(53%),p=0.231。
  • 非典型腺瘤组平均年龄37岁(范围10-65岁),显著低于非非典型腺瘤组的49岁(范围10-93岁),p<0.001。
  • 非典型腺瘤最常见症状为头痛(42%)和视力改变(33%)。
  • 非典型腺瘤更多为功能性(78%) vs 非非典型腺瘤(42%),p<0.001。

关键数值与推荐

  • 非典型性标志物包括核分裂指数、广泛p53染色和MIB-1指数≥3%。
  • 功能性非典型腺瘤平均直径2.2 cm vs 功能性非非典型腺瘤1.4 cm,p=0.009;非功能性非典型腺瘤3.3 cm vs 非功能性非非典型腺瘤2.3 cm,p=0.01。
  • 肿瘤较大与海绵窦侵犯相关(p<0.001);次全切除与海绵窦侵犯(p<0.001)和较大体积(p<0.001)相关(二项多因素回归)。
  • 复发中位时间:非典型腺瘤56个月,功能性非非典型腺瘤129个月,非功能性非非典型腺瘤204个月,p<0.001。
  • 校正切除范围、海绵窦侵犯、大小、年龄、性别和功能亚型后,非典型性仍为功能性腺瘤更早复发的显著预测因素(p=0.002)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE In 2004, the WHO classified atypical pituitary adenoma as a distinct adenoma subtype. However, the clinical significance of this distinction remains undetermined. The authors sought to define patient characteristics, tumor features, and treatment outcomes associated with atypical pituitary adenoma. METHODS The authors reviewed records of patients who underwent resection of pituitary adenoma at the University of California, San Francisco, between 2007 and 2014. Per institutional protocol, adenomas exhibiting mitotic activity underwent evaluation for all 3 markers of atypicality (mitotic index, extensive p53 staining, and MIB-1 index ≥ 3%). Statistical analyses were performed using χ2, Fisher's exact test, t-test, log-rank, and logistic regression. RESULTS Between 2007 and 2014, 701 patients underwent resection for pituitary adenoma. Among these patients, 122 adenomas exhibited mitotic activity and therefore were evaluated for all 3 markers of atypicality, with 36 tumors (5%) proving to be atypical. There were 21 female patients (58%) and 15 male patients (42%) in the atypical cohort, and 313 female patients (47%) and 352 male patients (53%) in the nonatypical cohort (p = 0.231). The mean age of patients in the atypical cohort was 37 years (range 10-65 years), which was significantly lower than the mean age of 49 years (range 10-93 years) for patients in the nonatypical cohort (p < 0.001). The most common presenting symptoms for patients with atypical adenomas were headaches (42%) and visual changes (33%). Atypical adenomas were more likely to be functional (78%) than nonatypical adenomas (42%; p < 0.001). Functional atypical adenomas were significantly larger than functional nonatypical adenomas (mean diameter 2.2 vs 1.4 cm; p = 0.009), as were nonfunctional atypical adenomas compared with nonfunctional nonatypical adenomas (mean diameter 3.3 vs 2.3 cm; p = 0.01). Among the entire adenoma cohort, larger presenting tumor size was associated with cavernous sinus invasion (p < 0.001), and subtotal resection was associated with cavernous sinus invasion (p < 0.001) and larger size (p < 0.001) on binomial multivariate regression. The median time until recurrence was 56 months for atypical adenomas, 129 months for functional nonatypical adenomas, and 204 months for nonfunctional nonatypical adenomas (p < 0.001). Functional atypical adenomas recurred more frequently and significantly earlier than functional nonatypical adenomas (p < 0.001). When accounting for extent of resection, cavernous sinus invasion, size, age, sex, and functional subtype, atypicality remained a significant predictor of earlier recurrence among functional adenomas (p = 0.002). CONCLUSIONS When compared with nonatypical pituitary adenomas, atypical adenomas are more likely to present in younger patients at a larger size, are more often hormonally hypersecretory, and are associated with earlier recurrence. These features lend credence to atypical pituitary adenomas being a distinct clinical entity in addition to a discrete pathological diagnosis.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Rutkowski MJ, Alward RM, Chen R, et al. Atypical pituitary adenoma: a clinicopathologic case series. J Neurosurg. 2017. PMID: 28598278. doi:10.3171/2016.12.JNS162126

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。